Instadose Pharma Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INSD research report →
About the company
Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.
- CEO
- Antonio Rocco Franchino
- IPO
- 2020
- Employees
- 2
- HQ
- Chesapeake, VA, US
Price Chart
- Market Cap
- $53.19K
- P/E
- -0.02
- P/S
- 0.00
- P/B
- -0.06
- EV/EBITDA
- -0.53
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 503.52%
- ROIC
- 372.55%
- Revenue
- $0 · 0.00%
- Net Income
- $-589,000 · -1668.08%
- EPS
- $-0.00 · -1500.00%
- Op Income
- $-462,023
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -401.63
- Avg Volume
- 569.524
Get TickerSpark's AI analysis on INSD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our INSD coverage
Recent articles, reports, and earnings notes.
No research on INSD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INSD report →Similar companies
Peers in the same neighborhood.